Zdrowie i gospodarka · 07/08/2018

FDA Releases Draft Guidance on Demonstrating Effectiveness of Medication-Assisted Treatment for Opioid Use Disorder

The FDA is releasing a draft guidance to help pharmaceutical companies demonstrate the effectiveness of medications for treating opioid use disorder, and is seeking public comments on the use of placebo or active controls in clinical trials for these drugs.